On March 10, FAIR Health launched a groundbreaking website feature that combines clinical and cost information to support seriously and chronically ill patients and their caregivers in the process of shared decision making (SDM) with clinicians for 3 palliative care scenarios.
The new feature is the most recent addition to fairhealthconsumer.org, FAIR Health’s free, award-winning consumer website, which enables consumers to estimate the typical costs of medical and dental procedures in their geographic areas and provides rich educational materials on the fundamentals of health insurance. A national, independent nonprofit organization dedicated to bringing transparency to healthcare costs and health insurance information, FAIR Health powers the cost information on FAIR Health Consumer with its database of billions of private healthcare claims—the largest in the nation. The same database provides the cost data for the new SDM feature, fairhealthconsumer.org/shared-decision-making.
SDM, the discussion between patients/caregivers and healthcare providers regarding various treatment options, has been known to increase patient engagement and reduce healthcare costs. But in the past, the utility of SDM tools, or decision aids, has been limited by the absence of cost data to complement the clinical information. As part of a pilot generously funded by The New York Community Trust (The Trust), the new SDM tool combines cost data from FAIR Health with Option Grid™ decision aids from EBSCO Information Services, cofounded by Dr. Glyn Elwyn, BA, MD, MSc, PhD, professor at the Geisel School of Medicine at Dartmouth College.
Intended to support the conversation between clinicians and patients/caregivers, and designed for ease of use, the decision aids offer clinical and cost information related to:
FAIR Health will collaborate with organizations and professionals who provide palliative care services in the New York metropolitan area in order to promote awareness of this resource. The project will also include an evaluation of the SDM tools to help inform future initiatives and tools.
Irfan Hasan, Program Director of Health and Behavioral Health at The Trust, commented: “Palliative care decisions in cases of serious and chronic illness are fraught with emotional and personal significance. The Trust is proud to support FAIR Health’s efforts to aid those decisions.”
Diane E. Meier, MD, Director of the Center to Advance Palliative Care, Icahn School of Medicine at Mount Sinai, stated: “Having witnessed the need for clear and accurate information when making critical health decisions during chronic and serious illness, I am heartened by FAIR Health’s effort to promote shared decision making for patients and caregivers when they most need clarity and guidance.”
The new shared decision-making tool on FAIR Health Consumer is a natural extension of our commitment to cost transparency and to helping consumers navigate the complexities of the healthcare system. We look forward to assisting patients and their caregivers as they make serious decisions in consultation with their clinicians.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Pulmonary Hypertension Subtypes Show Distinct PA Flow Hemodynamics
March 21st 2025Investigators used 4D flow cardiovascular magnetic resonance imaging to search for differences between pulmonary artery (PA) remodeling in pulmonary arterial hypertension and other types of pulmonary hypertension.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
FDA Approves Vutrisiran to Mitigate Cardiomyopathy-Related Risks and Conditions
March 21st 2025In a recent decision, the FDA approved vutrisiran (amvuttra), making it the only approved therapy for adults with hereditary transthyretin-mediated amyloidosis (ATTR-CM) or wild-type cardiomyopathy.
Read More
Streamlining "Brain-to-Vein" Time, Patient Selection, Imperative for Implementing CAR T for MM
March 21st 2025Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Pulmonary Hypertension Subtypes Show Distinct PA Flow Hemodynamics
March 21st 2025Investigators used 4D flow cardiovascular magnetic resonance imaging to search for differences between pulmonary artery (PA) remodeling in pulmonary arterial hypertension and other types of pulmonary hypertension.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
FDA Approves Vutrisiran to Mitigate Cardiomyopathy-Related Risks and Conditions
March 21st 2025In a recent decision, the FDA approved vutrisiran (amvuttra), making it the only approved therapy for adults with hereditary transthyretin-mediated amyloidosis (ATTR-CM) or wild-type cardiomyopathy.
Read More
Streamlining "Brain-to-Vein" Time, Patient Selection, Imperative for Implementing CAR T for MM
March 21st 2025Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.
Read More
2 Commerce Drive
Cranbury, NJ 08512